These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31446869)

  • 1. Successful switch to oral tacrolimus in a patient with hypersensitivity reaction to parenteral vitamin K, cyclosporine, and tacrolimus: A case report.
    Taghvaye-Masoumi H; Sadeghi K; Hadjibabaie M
    J Oncol Pharm Pract; 2020 Jun; 26(4):986-988. PubMed ID: 31446869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Well-tolerated oral cyclosporine in a case of hypersensitivity to parenteral cyclosporine in postallogeneic bone marrow transplantation.
    Moeinian M; Sotoude H; Mohebbi Z; Asadollahi-Amin A; Mozafari R
    Indian J Pharmacol; 2018; 50(2):94-96. PubMed ID: 30100659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipient.
    Takamatsu Y; Ishizu M; Ichinose I; Ogata K; Onoue M; Kumagawa M; Suzumiya J; Tamura K
    Bone Marrow Transplant; 2001 Aug; 28(4):421-3. PubMed ID: 11571519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity reaction to intravenous but not oral tacrolimus.
    Nicolai S; Bunyavanich S
    Transplantation; 2012 Nov; 94(9):e61-3. PubMed ID: 23128975
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous tacrolimus and cyclosporine induced anaphylaxis: what is next?
    Kang SY; Sohn KH; Lee JO; Kim SH; Cho SH; Chang YS
    Asia Pac Allergy; 2015 Jul; 5(3):181-6. PubMed ID: 26240796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcome of renal transplantation after tacrolimus switch to cyclosporine].
    Mesar I; Basić-Jukić N; Bubić-Filipi L; Kastelan Z; Bacak-Kocman I; Kes P
    Acta Med Croatica; 2011; 65(4):311-4. PubMed ID: 22359902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaphylaxis to intravenous cyclosporine and tolerance to oral cyclosporine: case report and review.
    Volcheck GW; Van Dellen RG
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):159-63. PubMed ID: 9494448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgE-mediated anaphylaxis after first intravenous infusion of cyclosporine.
    Ebo DG; Piel GC; Conraads V; Stevens WJ
    Ann Allergy Asthma Immunol; 2001 Sep; 87(3):243-5. PubMed ID: 11570623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe Anaphylaxis During Allogeneic Hematopoietic Stem Cell Transplantation in a Patient with Aplastic Anemia: Case Report of Individualized Pharmaceutical Care and Literature Review.
    Peng H; Ji D; Ren S; Zou D; Li F; Huang R
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion From Cyclosporine to Once-Daily Tacrolimus on 50:1 mg Basis: A Short-Term Pilot Study.
    Shimada H; Uchida J; Kosoku A; Iwai T; Kabei K; Nishide S; Naganuma T; Kumada N; Takemoto Y; Nakatani T
    Exp Clin Transplant; 2020 Feb; 18(1):1-7. PubMed ID: 31180299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin inhibitor-induced irreversible neuropathic pain after allogeneic hematopoietic stem cell transplantation.
    Fujii N; Ikeda K; Koyama M; Aoyama K; Masunari T; Kondo E; Matsuzaki T; Mizobuchi S; Hiraki A; Teshima T; Shinagawa K; Ishimaru F; Tanimoto M
    Int J Hematol; 2006 Jun; 83(5):459-61. PubMed ID: 16787880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous mycophenolate mofetil for graft-versus-host disease prophylaxis in an allogeneic hematopoietic stem cell transplant recipient with an allergic reaction to cyclosporine and tacrolimus.
    Dvorak CC; Callard E; Agarwal R
    Bone Marrow Transplant; 2006 Aug; 38(3):253-4. PubMed ID: 16785867
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study.
    Doesch AO; Mueller S; Konstandin M; Celik S; Erbel C; Kristen A; Frankenstein L; Koch A; Dengler TJ; Ehlermann P; Zugck C; De Geest S; Katus HA
    Transplant Proc; 2010 Dec; 42(10):4238-42. PubMed ID: 21168673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole.
    Mori T; Aisa Y; Kato J; Nakamura Y; Ikeda Y; Okamoto S
    Int J Hematol; 2009 Jul; 90(1):103-107. PubMed ID: 19472033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
    Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
    Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation.
    Doesch AO; Mueller S; Akyol C; Erbel C; Frankenstein L; Ruhparwar A; Ehlermann P; Dengler TJ; Katus HA
    Drug Des Devel Ther; 2013; 7():1253-8. PubMed ID: 24174870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of two-hour intermittent intravenous infusions of tacrolimus in the allogeneic hematopoietic stem cell transplantation unit.
    Bacopoulos AJ; Ho L; Yang A; Ng P; Dara C; Loach D; Deotare U; Michelis FV; Viswabandya A; Kim DD; Lipton JH; Messner HA; Thyagu S
    J Oncol Pharm Pract; 2021 Jan; 27(1):33-39. PubMed ID: 32183586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporine-induced anaphylaxis.
    Kuiper RA; Malingré MM; Beijnen JH; Schellens JH
    Ann Pharmacother; 2000; 34(7-8):858-61. PubMed ID: 10928395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Target blood concentrations of CYA and tacrolimus in randomized controlled trials for the prevention of acute GVHD after hematopoietic SCT.
    Oshima K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Kanda Y
    Bone Marrow Transplant; 2010 Apr; 45(4):781-2. PubMed ID: 19701249
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy.
    Weir MR; Ward MT; Blahut SA; Klassen DK; Cangro CB; Bartlett ST; Fink JC
    Kidney Int; 2001 Apr; 59(4):1567-73. PubMed ID: 11260422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.